Nateglinide, a New Mealtime Glucose Regulator
- 1 June 2000
- journal article
- Published by Springer Nature in Clinical Drug Investigation
- Vol. 19 (6) , 465-471
- https://doi.org/10.2165/00044011-200019060-00009
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Improved control of mealtime glucose excursions with coadministration of nateglinide and metformin.Diabetes Care, 2000
- Synergistic Effects of Nateglinide and Meal Administration on Insulin Secretion in Patients with Type 2 Diabetes MellitusJournal of Clinical Endocrinology & Metabolism, 2000
- Atorvastatin Coadministration May Increase Digoxin Concentrations by Inhibition of Intestinal P-Glycoprotein-Mediated SecretionThe Journal of Clinical Pharmacology, 2000
- P-GLYCOPROTEIN SYSTEM AS A DETERMINANT OF DRUG INTERACTIONS: THE CASE OF DIGOXIN–VERAPAMILPharmacological Research, 1999
- An interaction between digoxin and acarbose.Diabetes Care, 1999
- Inhibition of P-Glycoprotein–Mediated Drug TransportCirculation, 1999
- The Effect of Food on the Oral Bioavailability and the Pharmacodynamic Actions of the Insulinotropic Agent Nateglinide in Healthy SubjectsThe Journal of Clinical Pharmacology, 1999
- A possible interaction of potential clinical interest between digoxin and acarbose*Clinical Pharmacology & Therapeutics, 1996
- The bioavailability of digoxin from three oral formulations measured by a specific h.p.l.c. assay.Published by Wiley ,1993
- N-Acylphenylalanines and related compounds. A new class of oral hypoglycemic agentsJournal of Medicinal Chemistry, 1988